Skip to main content
Equibles

THOMPSON SIEGEL & WALMSLEY LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1008322 RICHMOND, VA
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$8,032,442
-$1,761,542 QoQ
Shares Held
12,882
+1.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#326
of 1,329 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

THOMPSON SIEGEL & WALMSLEY LLC holds $13,892,129 across 5 Biotechnology names. REGN ranks #1 (57.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page 		12,882 $8,032,442
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,408 $3,183,045
3 JAZZ
Jazz Pharmaceuticals plc
 5,045 $1,215,693
4 VIR
Vir Biotechnology, Inc.
 83,000 $845,770
5 FENC
Fennec Pharmaceuticals Inc.
 57,226 $615,179

All Filings in REGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,032,442 12,882
2026-03-31 $9,793,984 12,676
2025-12-31 $9,190,656 11,907
2025-09-30 $6,793,346 12,082
2025-06-30 $5,820,150 11,086
2025-03-31 $6,390,501 10,076
2024-12-31 $5,450,749 7,652
2024-09-30 $7,873,787 7,490
2024-06-30 $9,053,572 8,614
2024-03-31 $8,402,537 8,730
2023-12-31 $9,802,594 11,161
2023-09-30 $9,686,241 11,773
2023-06-30 $8,217,222 11,436
2023-03-31 $9,376,900 11,415
2022-12-31 $7,930,617 10,992
2022-09-30 $7,855,184 11,403
2022-06-30 $6,797,403 11,499
2022-03-31 $8,006,686 11,464
2021-12-31 $7,194,907 11,393
2021-09-30 $6,705,394 11,080
2021-06-30 $6,057,366 10,845